Tayanes, Gemma .

HRN: 28-80-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CEFUROXIME 1.5GM (VIAL)
04/07/2026
04/14/2026
IV
1.5
Ptor
Pelvic Lap
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: